MedPath

C-Reactive Protein/Albumin Ratio and Acne Vulgaris

Completed
Conditions
Acne Vulgaris
Interventions
Diagnostic Test: Biochemical blood analysis
Registration Number
NCT06004583
Lead Sponsor
Ataturk University
Brief Summary

Objective: Acne vulgaris, an inflammatory disease, was investigated in this study with the claim that C-reactive protein (CRP) / albumin ratio and some hematological parameter ratios have the potential to be used as inflammatory markers to monitor disease severity and prognosis.

Methods: A descriptive cross-sectional study was conducted with two groups of patients aged 18-65 years, 61 patients diagnosed with acne vulgaris and 35 healthy control patients, and routine hemogram and biochemical parameters were compared. The Global Acne Severity Index was used to determine the severity of acne vulgaris.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
96
Inclusion Criteria
  • Acne vulgaris patients diagnosed by a dermatologist
  • Healthy participants without acne
  • 18-40 years of age
  • Voluntary participation
Exclusion Criteria
  • Aged below18 or above 40 years
  • Not voluntarily participated patents
  • Pregnants, breast milked mothers, emergency situations

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Control groupBiochemical blood analysisHealthy participants
Acne groupBiochemical blood analysisAcne Vulgaris Diagnosed Patients
Primary Outcome Measures
NameTimeMethod
CRP/albumin ratio3 months

Statistical difference between groups

Secondary Outcome Measures
NameTimeMethod
Usage of CRP/albumin ratio as a Biomarker3 months

New detection of CRP/albumin ratio as a new biomarker in the Acne patients

Trial Locations

Locations (1)

AtaturkU

🇹🇷

Erzurum, Turkey

© Copyright 2025. All Rights Reserved by MedPath